With the outstanding and progressive trial reports and such, it's no longer a question of of RAP will get FDA approval but WHEN they will be granted FDA approval...
I've held for over a year and I just bought some recently... IMO a buy under 30c is a bargain...
RAP could be a monopoly for all I could imagine... There's no other competitor that has even reach the in depth achievements of RAP or have come close to achiving clinical trial results a year ago. Once they receive FDA approval, deals and negotiation will flow in.
There is no such thing as get rich quick... Patience is the key to everything. GLTA.
RAP charting, page-8389
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #